Xcellerate Biotech, Inc. — Form D
Xcellerate Biotech, Inc. of Rockville, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-27. The offering totals $719K, of which $719K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-27
- Form: D
- Accession: 0001795036-20-000001
- Industry: Biotechnology
- Exemptions: 06b, 4a5
- Total offering: $719K
- Amount sold: $719K
- Minimum investment: $719K
- Investors: 1
- Date of first sale: 2020-08-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374274
Issuer
- Name: Xcellerate Biotech, Inc.
- CIK: 0001795036
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 13212 Valley Drive, Rockville, MD, 20850
- Phone: 240-620-2394
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Peter Dolan | Director | Bedford, MA |
| Peter Dolan | Executive Officer | Bedford, MA |
| Peter Dolan | Promoter | Bedford, MA |
Other filings by this issuer (1)
More